Nikita Mehta
Overview
Explore the profile of Nikita Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keung M, Mehta N, Lynn E, Pineda E, Fetene D, Lee A, et al.
J Virol Methods
. 2025 Mar;
335:115145.
PMID: 40054738
This study assessed the relative clinical sensitivity and specificity for cervical precancer of the Roche cobas HPV test when processed using the Roche cobas 6800 system using the Roche cobas...
2.
Mehta N, Keung M, Pineda E, Lynn E, Fetene D, Lee A, et al.
Microbiol Spectr
. 2024 Sep;
12(10):e0149324.
PMID: 39258912
This study assessed the relative clinical sensitivity and specificity, as well as reproducibility, for high-risk HPV types of the Roche cobas HPV test when processed using the Roche cobas 5800...
3.
Ceyhan-Birsoy O, Fiala E, Rana S, Sheehan M, Kennedy J, Yelskaya Z, et al.
Haematologica
. 2024 Apr;
109(10):3383-3390.
PMID: 38572560
No abstract available.
4.
Maierhofer A, Mehta N, Chisholm R, Hutter S, Baer C, Nadarajah N, et al.
Blood Adv
. 2023 Oct;
7(23):7346-7357.
PMID: 37874914
Deleterious germ line variants in DDX41 are a common cause of genetic predisposition to hematologic malignancies, particularly myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML). Targeted next-generation sequencing was performed...
5.
Mehta N, Inamdar V, Puthillam A, Chunekar S, Kapoor H, Tagat A, et al.
Wellcome Open Res
. 2023 Aug;
7:157.
PMID: 37636840
The coronavirus disease 2019 (COVID-19) pandemic and the nationally mandated lockdown has resulted in facility closures, decreased laboratory activities, and shifting to remote working. The effects of the pandemic have...
6.
Mandelker D, Marra A, Zheng-Lin B, Selenica P, Blanco-Heredia J, Zhu Y, et al.
J Clin Oncol
. 2023 Aug;
41(33):5151-5162.
PMID: 37607324
Purpose: To determine the genetic predisposition underlying pancreatic acinar cell carcinoma (PACC) and characterize its genomic features. Methods: Both somatic and germline analyses were performed using an Food and Drug...
7.
Ranganathan M, Sacca R, Trottier M, Maio A, Kemel Y, Salo-Mullen E, et al.
JCO Precis Oncol
. 2023 Jun;
7:e2200675.
PMID: 37262391
Purpose: Lynch syndrome (LS)-associated colorectal cancer (CRC) is characterized by mismatch repair-deficiency (MMR-D) and/or microsatellite instability (MSI). However, with increasing utilization of germline testing, MMR-proficient (MMR-P) and/or microsatellite stable (MSS)...
8.
Mandelker D, Marra A, Mehta N, Selenica P, Yelskaya Z, Yang C, et al.
NPJ Precis Oncol
. 2023 Jan;
7(1):1.
PMID: 36593350
Traditional genetic testing for patients with gastrointestinal stromal tumors (GISTs) focus on those with syndromic features. To assess whether expanded genetic testing of GIST patients could identify hereditary cancer predisposition,...
9.
Truong H, Breen K, Nandakumar S, Sjoberg D, Kemel Y, Mehta N, et al.
Eur Urol
. 2022 Sep;
83(1):29-38.
PMID: 36115772
Background: Tumor-only genomic profiling is an important tool in therapeutic management of men with prostate cancer. Since clinically actionable germline variants may be reflected in tumor profiling, it is critical...
10.
Liu Y, Maio A, Kemel Y, Salo-Mullen E, Sheehan M, Tejada P, et al.
Cancer
. 2022 Aug;
128(21):3870-3879.
PMID: 36041233
Background: Germline risk assessment is increasing as part of cancer care; however, disparities in subsequent genetic counseling are unknown. Methods: Pan-cancer patients were prospectively consented to tumor-normal sequencing via custom...